Home / Sweden / Apotea AB (publ)
Apotea AB (publ)
Short position disclosed on August 10, 2026.
1.96% of the capital sold short
3 disclosing funds
67 disclosures on record
SE0023313762 ISIN code
Evolution of the disclosed total
0%2%4%6%
Mar 2026May 2026Jul 2026
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Advisors LLC | 0.79% | +0.28 pt | July 30, 2026 | |
| Walleye Capital LLC | 0.59% | new | May 28, 2026 | |
| Acadian Asset Management LLC | 0.58% | new | August 10, 2026 |
On the other side: the funds that hold Apotea AB (publ) Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 9, 2026 | Acadian Asset Management LLC | 0.65% | still open |
| March 6, 2026 | JPMorgan Asset Management (UK) Ltd | 0.61% | still open |
| March 4, 2026 | Acadian Asset Management LLC | 0.58% | still open |
| March 2, 2026 | Qube Research & Technologies Limited | 0.92% | still open |
| February 27, 2026 | Citadel Advisors LLC | 0.92% | still open |
| February 26, 2026 | Qube Research & Technologies Limited | 0.80% | still open |
| February 26, 2026 | Walleye Capital LLC | 0.60% | still open |
| February 26, 2026 | Marshall Wace LLP | 0.50% | still open |
| February 24, 2026 | Citadel Advisors LLC | 0.83% | still open |
| February 24, 2026 | Qube Research & Technologies Limited | 0.71% | still open |
| February 23, 2026 | Qube Research & Technologies Limited | 0.66% | still open |
| February 20, 2026 | Citadel Advisors LLC | 0.72% | still open |
| February 18, 2026 | Walleye Capital LLC | 0.50% | still open |
| February 17, 2026 | Citadel Advisors LLC | 0.62% | still open |
| February 17, 2026 | Qube Research & Technologies Limited | 0.50% | still open |
| February 11, 2026 | Citadel Advisors LLC | 0.54% | still open |
| February 6, 2026 | Citadel Advisors LLC | 0.51% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.26% of the capital sold short
- Elekta AB (publ) 9.63% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Embracer Group AB 5.75% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- RaySearch Laboratories AB (publ) 4.16% of the capital sold short
- Dynavox Group AB 3.80% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Apotea AB (publ), source Finansinspektionen, data as at August 10, 2026, https://www.quivad.com/action/apotea-ab-publ?page=2